A-dmDT390-bisFv(UCHT1) Immunotoxin Therapy for Patients With Cutaneous T-Cell Lymphoma (CTCL)

Clinical trial NCT00611208 · COMPLETED

Trial details

NCT number: NCT00611208
Sponsor: Virogen Biotechnology Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

T-cell Lymphomas T-cell Leukemia Sezary Syndrome Mycosis Fungoides Cutaneous T-cell Lymphoma (CTCL)

Start date: 2008-01-01
Primary completion: 2015-02-01
Enrollment: 32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.